Related Experiment Video

Updated: Apr 18, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

14.7K

Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage

Melissa W Y Chua1, Mike Z Lin, Janet L Martin

  • 1Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.

Journal of Cell Communication and Signaling
|January 25, 2015
PubMed

Insights

Insulin-like growth factor-binding proteins (IGFBPs) play a role in cancer cell protection against DNA damage. Understanding IGFBP involvement in DNA repair pathways could enhance cancer treatment sensitivity.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Cells possess complex DNA damage response mechanisms that cancer cells exploit for protection against chemotherapy and radiotherapy.
  • Insulin-like growth factor-binding proteins (IGFBPs) are implicated in these protective pathways, interacting with key regulators like p53 and DNA repair machinery.
  • The p53 tumor suppressor protein, a critical sensor of genotoxic stress, influences the expression of IGFBP genes, highlighting a molecular link.

Purpose of the Study:

  • To elucidate the role of IGFBPs in cellular defense against DNA damage, particularly in the context of cancer.
  • To investigate the interaction of IGFBPs with DNA repair pathways, including non-homologous end-joining (NHEJ).
  • To explore how IGFBPs modulate cell fate decisions following DNA damage, such as apoptosis or senescence.

Main Methods:

  • Analysis of p53 response elements in IGFBP gene promoters and intronic regions.
  • Investigation of IGFBP interactions with DNA repair proteins, including epidermal growth factor receptor (EGFR) and DNA-PK.
  • Examination of IGFBP influence on sphingolipid metabolism (ceramide and sphingosine-1-phosphate).

Main Results:

  • All six human IGFBP genes possess p53-responsive elements, with IGFBP3 being a well-characterized p53-inducible gene.
  • IGFBP-3 and IGFBP-6 interact with components of the NHEJ pathway; IGFBP-3 directly binds EGFR and DNA-PK.
  • IGFBPs can modulate the balance of ceramide and sphingosine-1-phosphate, influencing cell fate after DNA damage.

Conclusions:

  • IGFBPs are integral to cancer cell survival mechanisms by influencing DNA damage response and repair.
  • Targeting IGFBP interactions within DNA repair pathways, such as NHEJ, presents a potential strategy to overcome treatment resistance.
  • Further understanding of IGFBPs in DNA damage response may lead to novel approaches for sensitizing cancers to genotoxic therapies.

More Related Videos

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay13:10

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay

Published on: June 9, 2017

10.8K
Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

11.4K

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K